Stay updated with breaking news from Repligen Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ledyard National Bank trimmed its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 4.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,933 shares of the biotechnology company’s stock after selling 944 shares during the period. Ledyard National Bank’s […]
Repligen Co. (NASDAQ:RGEN – Free Report) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $142.56 and last traded at $142.78, with a volume of 73224 shares changing hands. The stock had previously closed at $150.57. Analyst Upgrades and Downgrades RGEN has been the subject of […]
Shares of Repligen Co. (NASDAQ:RGEN – Get Rating) have received a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective among […]
American Capital Management Inc. boosted its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 14.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 140,751 shares of the biotechnology company’s stock after purchasing an additional 17,827 shares during the quarter. American […]
American Capital Management Inc. lifted its holdings in Repligen Co. (NASDAQ:RGEN – Get Rating) by 14.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 140,751 shares of the biotechnology company’s stock after buying an additional 17,827 shares during the quarter. American Capital Management Inc. […]